BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33842349)

  • 21. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
    Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
    Front Immunol; 2020; 11():621623. PubMed ID: 33613554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy.
    Yang S; Guan H; Wang S; Wu H; Sun W; Chen Z; Li Q
    Cancer Manag Res; 2020; 12():9303-9314. PubMed ID: 33061620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
    Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
    Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
    Obayashi K; Miki J; Fukuokaya W; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
    Int J Clin Oncol; 2022 Feb; 27(2):396-402. PubMed ID: 34714458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer.
    Su S; Liu L; Sun C; Yang L; Nie Y; Chen Y; Zhang J; Li S
    Urol Oncol; 2020 Nov; 38(11):852.e1-852.e9. PubMed ID: 32624424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma.
    Xie D; Wang TT; Huang SJ; Deng JJ; Ren YJ; Yang Y; Wu JQ; Zhang L; Fei K; Sun XW; She YL; Chen C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1112-1123. PubMed ID: 32953490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
    Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis.
    Pan YB; Zhu Y; Zhang QW; Zhang CH; Shao A; Zhang J
    Front Oncol; 2020; 10():1057. PubMed ID: 32793467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 7-gene signature predicts the prognosis of patients with bladder cancer.
    Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
    BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
    Labban M; Najdi J; Mukherji D; Abou-Kheir W; Tabbarah A; El-Hajj A
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1313. PubMed ID: 33538412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Up Staging.
    de Jong JJ; Liu Y; Boorjian SA; Bivalacqua TJ; Porten SP; Wheeler T; Davicioni E; Svatek RS; Boormans JL; Black PC; Lotan Y; Gibb EA
    J Urol; 2020 Aug; 204(2):239-246. PubMed ID: 32074006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.
    Zhang W; Wang R; Ma W; Wu Y; Maskey N; Guo Y; Liu J; Mao S; Zhang J; Yao X; Liu Y
    Ann Transl Med; 2019 Sep; 7(18):431. PubMed ID: 31700867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.